Stay updated on Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The record describes a terminated Phase 2 study of ipilimumab and nivolumab for recurrent HER2-negative inflammatory breast cancer, including its eligibility criteria, study outcomes, and a linked protocol document.
    Difference
    63%
    Check dated 2026-11-08T05:17:43.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.8.0 instead of v3.7.2, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:55:11.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with a link to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T03:11:07.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T03:00:58.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T05:14:45.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the usual study details, indicating an access restriction or server issue.
    Difference
    21%
    Check dated 2026-09-20T02:02:58.000Z thumbnail image

Stay in the know with updates to Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.